Treatment of ovarian damage induced by chemotherapeutic drugs in female rats with G-CSF and platelet-rich plasma(PRP): an immunohistochemical study correlation with novel marker INSL-3

References

• Kawamura K, Ishizuka B, Hsueh AJ. Rug-free in-vitro activation of follicles for infertility treatment in poor ovarian response patients with decreased ovarian reserve. Reprod Biomed Online. 2020;40(2):1–8. doi:10.1016/j.rbmo.2019.09.007.
   PubMed Web of Science ®Google Scholar
• Luo X, Xu J, Zhao R, et al. The role of inactivated NF-κB in premature ovarian failure. Am J Pathol. 2022;192(3):468–483. Mar 1 doi:10.1016/j.ajpath.2021.12.005.
   PubMed Web of Science ®Google Scholar
• Wang H, Chen H, Qin Y, et al. Risks associated with premature ovarian failure in han chinese women. Reprod Biomed Online. 2015;30(4):401–407. doi:10.1016/j.rbmo.2014.12.013.
   PubMed Web of Science ®Google Scholar
• Busnelli A, Vitagliano A, Mensi L, et al. Fertility in female cancer survivors: a systematic review and meta-analysis. Reprod Biomed Online. 2020;41(1):96–112. doi:10.1016/j.rbmo.2020.02.008.
   PubMed Web of Science ®Google Scholar
• Spears N, Lopes F, Stefansdottir A, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019;25(6):673–693. Nov 5 doi:10.1093/humupd/dmz027.
   PubMed Web of Science ®Google Scholar
• Pascuali N, Scotti L, Di Pietro M, et al. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure. Hum Reprod. 2018;33(5):844–859. doi:10.1093/humrep/dey045.
   PubMed Web of Science ®Google Scholar
• Hassanpour A, Yousefian S, Askaripour M, et al. Ovarian protection in cyclophosphamide-treated mice by fennel. Toxicol Rep. 2017;4:160–164. doi:10.1016/j.toxrep.2017.03.002.
   PubMedGoogle Scholar
• Barberino RS, Silva RL, Palheta Junior RC, et al. Protective effects of antioxidants on Cyclophosphamide-Induced ovarian toxicity. Biopreserv Biobank. 2022;21(2):121–141. doi:10.1089/bio.2021.0159.
   PubMed Web of Science ®Google Scholar
• Chang EM, Lim E, Yoon S, et al. Cisplatin induces overactivation of the dormant primordial follicle through PTEN/AKT/FOXO3a pathway which leads to loss of ovarian reserve in mice. PLoS One. 2015 2;10(12):e0144245. doi:10.1371/journal.pone.0144245.
   PubMed Web of Science ®Google Scholar
• Seckin S, Ramadan H, Mouanness M, et al. Ovarian response to intraovarian platelet-rich plasma (PRP) administration: hypotheses and potential mechanisms of action. J Assist Reprod Genet. 2022;39(1):37–61. doi:10.1007/s10815-021-02385-w.
   PubMed Web of Science ®Google Scholar
• Bakacak M, Bostanci MS, İnanc F, et al. Protective effect of platelet rich plasma on experimental ischemia/reperfusion injury in rat ovary. Gynecol Obstet Invest. 2016;81(3):225–231. doi:10.1159/000440617.
   PubMed Web of Science ®Google Scholar
• Pintat J, Silvestre A, Magalon G, et al. Intra-articular injection of mesenchymal stem cells and platelet-rich plasma to treat patellofemoral osteoarthritis: preliminary results of a Long-Term pilot study. J Vasc Interv Radiol. 2017;28(12):1708–1713. doi:10.1016/j.jvir.2017.08.004.
   PubMed Web of Science ®Google Scholar
• Le ADK, Enweze L, DeBaun MR, et al. Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med. 2018;11(4):624–634. doi:10.1007/s12178-018-9527-7.
   PubMed Web of Science ®Google Scholar
• Ozcan P, Takmaz T, Tok OE, et al. The protective effect of platelet-rich plasma administrated on ovarian function in female rats with Cy-induced ovarian damage. J Assist Reprod Genet. 2020;37(4):865–873. Apr doi:10.1007/s10815-020-01689-7.
   PubMed Web of Science ®Google Scholar
• Bostanci MS, Budak Ö, Çakiroğlu H, et al. The effectiveness of granulocyte Colony-Stimulating factor (G-CSF) against experimental ischemia–reperfusion injury in rat ovaries and its effect on in vitro fertilization outcomes. Reprod Sci. 2022;30(5):1660–1667. Novdoi:10.1007/s43032-022-01132-5.
   PubMed Web of Science ®Google Scholar
• Akdemir A, Zeybek B, Akman L, et al. Granulocyte-colony stimulating factor decreases the extent of ovarian damage caused by cisplatin in an experimental rat model. J Gynecol Oncol. 2014;25(4):328–333. Oct 1 doi:10.3802/jgo.2014.25.4.328.
   PubMed Web of Science ®Google Scholar
• Ivell R, Anand-Ivell R. Insulin-like peptide 3 (INSL3) is a major regulator of female reproductive physiology. Hum Reprod Update. 2018;24(6):639–651. doi:10.1093/humupd/dmy029.
   PubMed Web of Science ®Google Scholar
• Zhu C, Luo W, Li Z, et al. New theca-cell marker insulin-like factor 3 is associated with premature ovarian insufficiency. Fertil Steril. 2021;115(2):455–462. Feb 1 doi:10.1016/j.fertnstert.2020.08.005.
   PubMed Web of Science ®Google Scholar
• Tilly JL. Ovarian follicle counts—not as simple as 1, 2, 3. Reprod Biol Endocrinol. 2003;1(1):11. doi:10.1186/1477-7827-1-11.
   PubMedGoogle Scholar
• Li M, Zhu Y, Wei J, et al. The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis. Climacteric. 2022;14:1–8.
   Google Scholar
• Bedoschi G, Navarro PA, Oktay K. Chemotherapy-induced damage to ovary: mechanisms and clinical impact. Future Oncol. 2016;12(20):2333–2344. doi:10.2217/fon-2016-0176.
   PubMed Web of Science ®Google Scholar
• Terren C, Munaut C. Molecular basis associated with the control of primordial follicle activation during transplantation of cryopreserved ovarian tissue. Reprod Sci. 2021;28(5):1257–1266. May doi:10.1007/s43032-020-00318-z.
   PubMed Web of Science ®Google Scholar
• Cosgrove CM, Salani R. Ovarian effects of radiation and cytotoxic chemotherapy damage. Best Pract Res Clin Obstet Gynaecol. 2019;55:37–48. doi:10.1016/j.bpobgyn.2018.07.008.
   PubMed Web of Science ®Google Scholar
• Dehghani F, Aboutalebi H, Esmaeilpour T, et al. Effect of platelet-rich plasma (PRP) on ovarian structures in cyclophosphamide-induced ovarian failure in female rats: a stereological study. Toxicol Mech Methods. 2018;28(9):653–659. doi:10.1080/15376516.2018.1491662.
   PubMed Web of Science ®Google Scholar
• Pusch WO, Balvers MA, Ivell RI. Molecular cloning and expression of the relaxin-like factor from the mouse testis. Endocrinology. 1996;137(7):3009–3013. doi:10.1210/endo.137.7.8770925.
   PubMed Web of Science ®Google Scholar
• Bamberger AM, Ivell R, Balvers M, et al. Relaxin-like factor (RLF): a new specific marker for leydig cells in the ovary. Int J Gynecol Pathol. 1999;18(2):163–168. doi:10.1097/00004347-199904000-00011.
   PubMed Web of Science ®Google Scholar
• Telfer EE, Anderson RA. The existence and potential of germline stem cells in the adult mammalian ovary. Climacteric. 2019;22(1):22–26. doi:10.1080/13697137.2018.1543264.
   PubMed Web of Science ®Google Scholar
• Johnson J, Canning J, Kaneko T, et al. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004;428(6979):145–150. doi:10.1038/nature02316.
   PubMed Web of Science ®Google Scholar
• Huang Q, Liu B, Jiang R, et al. G-CSF-mobilized peripheral blood mononuclear cells combined with platelet-rich plasma accelerate restoration of ovarian function in cyclophosphamide-induced POI rats. Biol Reprod. 2019;101(1):91–101. doi:10.1093/biolre/ioz077.
   PubMed Web of Science ®Google Scholar